Companies have tried for decades to deliver protein-based drugs orally. Can Mir Imran and his company’s robotic pill succeed where so many have failed?
Mir Imran has been building medical device companies for 40 years. Perhaps known best for his work on the first FDA-approved implantable cardioverter defibrillator, Imran’s model is to identify big, unsolved challenges and try to find solutions.
His work at Rani Therapeutics, developing an oral drug-delivery capsule to replace painful injections, is no exception. Administering biologics orally has been attempted by 100 different people over the last fifty years, with no success, according to Imran.
Get the full story at our sister site, Drug Delivery Business News.
